| Feb 17, 2026 |
Feb 19, 2026 |
LSP 7 Cooperative UA
|
Director |
Neutral |
85.0
|
+358,680
|
7.28%
|
✗
|
- |
| Feb 17, 2026 |
Feb 18, 2026 |
Verduyn-van Weegen Felice Isabel
|
Director |
Neutral |
85.0
|
+358,680
|
7.28%
|
✗
|
- |
| Feb 17, 2026 |
Feb 17, 2026 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Neutral |
77.5
|
+35,868
|
1.34%
|
✗
|
- |
| Dec 19, 2025 |
Dec 22, 2025 |
Hopfner Robert Lorne
|
Director |
Buy |
48.8
|
+1,000
|
0.03%
|
✗
|
$17.4K |
| Dec 8, 2025 |
Dec 19, 2025 |
Bauer Eugene
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 9, 2025 |
Dec 11, 2025 |
Pena Luis C.
|
CEO |
Sell |
40.0
|
-28,138
|
-4.12%
|
✗
|
$502K |
| Dec 9, 2025 |
Dec 11, 2025 |
Patel Jeegar Pravinkumar
|
Chief Scientific Officer |
Sell |
42.5
|
-7,513
|
-13.16%
|
✗
|
$134K |
| Dec 9, 2025 |
Dec 11, 2025 |
Moss Gregory S.
|
Chief Business & Legal Officer |
Sell |
42.5
|
-13,624
|
-17.55%
|
✗
|
$243.1K |
| Dec 9, 2025 |
Dec 11, 2025 |
Drew Janice Suzann
|
EVP, Operations |
Sell |
42.5
|
-5,074
|
-6.96%
|
✗
|
$90.5K |
| Dec 9, 2025 |
Dec 11, 2025 |
Carver Kyle
|
CFO |
Sell |
42.5
|
-13,290
|
-17.53%
|
✗
|
$237.1K |
| Dec 9, 2025 |
Dec 11, 2025 |
Bauer Eugene
|
Chief Medical Officer |
Sell |
48.8
|
-1,478
|
-0.54%
|
✗
|
$26.4K |
| Nov 7, 2025 |
Nov 12, 2025 |
Pivotal bioVenture Partners Fund I, L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 7, 2025 |
Nov 12, 2025 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Buy |
100.0
|
+1,250,000
|
56.59%
|
✗
|
$20M |
| Nov 7, 2025 |
Nov 12, 2025 |
LSP 7 Cooperative UA
|
10% Owner |
Buy |
100.0
|
+1,562,500
|
46.40%
|
✗
|
$25M |
| Nov 7, 2025 |
Nov 12, 2025 |
Verduyn-van Weegen Felice Isabel
|
Director |
Buy |
100.0
|
+1,562,500
|
46.40%
|
✗
|
$25M |
| Nov 7, 2025 |
Nov 12, 2025 |
Pena Luis C.
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 7, 2025 |
Nov 12, 2025 |
Patel Jeegar Pravinkumar
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 7, 2025 |
Nov 12, 2025 |
Moss Gregory S.
|
Chief Business & Legal Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 7, 2025 |
Nov 12, 2025 |
Hopfner Robert Lorne
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 7, 2025 |
Nov 12, 2025 |
Drew Janice Suzann
|
EVP, Operations |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 7, 2025 |
Nov 12, 2025 |
Cohen David E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 7, 2025 |
Nov 12, 2025 |
Carver Kyle
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 7, 2025 |
Nov 12, 2025 |
Bauer Eugene
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 5, 2025 |
Nov 7, 2025 |
Cohen David E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 5, 2025 |
Nov 7, 2025 |
KIRSCH ARTHUR S
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 5, 2025 |
Nov 7, 2025 |
MCGRAW BENJAMIN F III
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 5, 2025 |
Nov 7, 2025 |
Patel Jeegar Pravinkumar
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 5, 2025 |
Nov 7, 2025 |
Drew Janice Suzann
|
EVP, Operations |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 5, 2025 |
Nov 7, 2025 |
Pena Luis C.
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 5, 2025 |
Nov 7, 2025 |
Carver Kyle
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 5, 2025 |
Nov 7, 2025 |
Moss Gregory S.
|
Chief Business & Legal Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Nov 5, 2025 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Nov 5, 2025 |
LSP 7 Cooperative UA
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Nov 5, 2025 |
Pivotal bioVenture Partners Fund I, L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Nov 5, 2025 |
Verduyn-van Weegen Felice Isabel
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Nov 5, 2025 |
Pena Luis C.
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Nov 5, 2025 |
Patel Jeegar Pravinkumar
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Nov 5, 2025 |
Moss Gregory S.
|
Chief Business & Legal Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Nov 5, 2025 |
MCGRAW BENJAMIN F III
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Nov 5, 2025 |
KIRSCH ARTHUR S
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Nov 5, 2025 |
Hopfner Robert Lorne
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Nov 5, 2025 |
Drew Janice Suzann
|
EVP, Operations |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Nov 5, 2025 |
DiRocco Derek
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Nov 5, 2025 |
Cohen David E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Nov 5, 2025 |
Carver Kyle
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Nov 5, 2025 |
Bauer Eugene
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |